Mark Heuring: Bridging the Gap Between Innovation and Real-World Healthcare Adoption

Founder of Healion Global on why regulatory approval is just the beginning of the journey to market success

Mark Heuring founded Healion Global, a consultancy focused on the MedTech and digital health market entry, commercial strategy, and fractional commercial leadership. One recurring observation has shaped his career: regulatory compliance enables market entry, but it does not guarantee commercial success.

Whether working with a medical device or a Software as a Medical Device (SaMD) solution, Mark has seen time and again that real adoption depends on far more than regulatory clearance alone. Regulatory, reimbursement, market access, and commercial execution all have to work together for a technology to take hold. His role is to connect these elements and turn a market opportunity into a viable pathway to adoption in healthcare.

The Gap That Drives Him

What drives Mark is the persistent gap between innovation and real-world adoption. He has watched strong technologies fall short of their potential because funding remained unclear, procurement proved difficult, the commercial setup was misaligned, or the solution did not fit existing clinical workflows.

For Mark, the work starts by identifying the barrier standing between a technology and its adoption, then developing a practical way to address it.

Beyond Strategy: Staying Involved Through Execution

Ask Mark what makes him proud of Healion Global, and the answer is immediate: the work continues beyond strategy. Healion Global connects commercial strategy with regulatory, reimbursement, and market access considerations, supporting companies from market entry planning through commercial execution. Mark combines hands-on commercial leadership with an international network of industry experts and business partners.

That means asking structural questions: Can the technology meet the requirements of the target market? Who pays for it? Who makes the decision? How should the market be approached? Depending on the answers, the decision can mean developing direct sales capabilities, selecting strategic distributors, or creating a hybrid commercial model.

Mark is clear that Healion Global’s role goes beyond recommending a route forward. Beyond strategy, Healion Global supports companies through hands-on business development, international sales expansion, distributor network development, and fractional commercial leadership, taking on temporary commercial leadership responsibilities without the need for a permanent executive appointment. Mark draws on his international network to identify and qualify partners, support negotiations, and implement the commercial setup. As he puts it, consulting is also about helping make it happen.

Turning Complexity into Action

To stay productive amid the complexity of healthcare projects, Mark returns regularly to three questions: What is the real objective? What is blocking it? And what is the next action with the highest impact? In an industry where it is easy to confuse activity with progress, this habit helps him focus on what moves a project forward.

Solving the Problem Beneath the Problem

One challenge Mark encounters repeatedly is working with technologies that are clinically strong and meet regulatory requirements, yet still lack a complete pathway to adoption. The instinctive response from teams in this position is often, “We need more sales.” Increasing sales activity alone does not necessarily solve the underlying problem; the bottleneck may also lie in commercial execution itself.

The friction may lie in reimbursement, funding, procurement, evidence generation, workflow integration, distribution, or partners without the right capabilities. Healion Global’s approach is to map the adoption pathway and identify the obstacles before deciding which commercial actions to take.

As Mark frames it, regulatory compliance enables market entry. Reimbursement, funding, and procurement pathways influence commercial viability. Effective commercial execution helps turn an opportunity into sustainable adoption.

His Advice for the Next Generation

For those starting out in MedTech and Digital Health today, Mark’s advice is direct: understand the system the product has to enter, as well as the product itself. That means learning how evidence, reimbursement, funding, procurement, and commercial decision-making interact.

He encourages newcomers to spend real time with clinicians, payers, procurement teams, distributors, and the people who will implement the technology day to day. Above all, he stresses one principle: listen before you sell. Sustainable growth in MedTech and digital health, he says, comes from understanding who benefits, who pays, who decides, and what has to change for adoption to happen.

LINKEDIN | WEBSITE

Also Read: Wally Blattner: Building Something Worthwhile and Doing Something Good

Alexey Gubarev: Leading Global Infrastructure Through Bold Investment, Health Innovation, and Community Impact